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Abstract
Background: Fetal and neonatal mortality rates in low-income countries are at least 10-fold greater than in high-income
countries. These differences have been related to poor access to and poor quality of obstetric and neonatal care.
Methods: This trial tested the hypothesis that teams of health care providers, administrators and local residents can
address the problem of limited access to quality obstetric and neonatal care and lead to a reduction in perinatal
mortality in intervention compared to control locations. In seven geographic areas in five low-income and one
middle-income country, most with high perinatal mortality rates and substantial numbers of home deliveries, we
performed a cluster randomized non-masked trial of a package of interventions that included community mobilization
focusing on birth planning and hospital transport, community birth attendant training in problem recognition, and
facility staff training in the management of obstetric and neonatal emergencies. The primary outcome was perinatal
mortality at ≥28 weeks gestation or birth weight ≥1000 g.
Results: Despite extensive effort in all sites in each of the three intervention areas, no differences emerged in the
primary or any secondary outcome between the intervention and control clusters. In both groups, the mean perinatal
mortality was 40.1/1,000 births (P = 0.9996). Neither were there differences between the two groups in outcomes in
the last six months of the project, in the year following intervention cessation, nor in the clusters that best
implemented the intervention.
Conclusions: This cluster randomized comprehensive, large-scale, multi-sector intervention did not result in detectable
impact on the proposed outcomes. While this does not negate the importance of these interventions, we expect that
achieving improvement in pregnancy outcomes in these settings will require substantially more obstetric and neonatal
care infrastructure than was available at the sites during this trial, and without them provider training and community
mobilization will not be sufficient. Our results highlight the critical importance of evaluating outcomes in randomized
trials, as interventions that should be effective may not be.
Trial registration: ClinicalTrials.gov NCT01073488
Keywords: Stillbirth, Neonatal mortality, Maternal mortality, Emergency obstetric care
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Background
Complications during labor and delivery are responsible
for half the maternal deaths, one-third of stillbirths and a
quarter of neonatal deaths occurring each year worldwide
[1-8]. These complications, for example, prolonged labor,
preeclampsia, infection and hemorrhage, also cause a
substantial amount of maternal morbidity and stillbirths
and contribute to neonatal mortality and long-term
disability [1,2,6]. Antenatal assessment often fails to
predict which women will have complications and
when these will occur. Their effective management often
necessitates urgent, facility-based management of labor
by a skilled birth attendant with the ability to provide
parenteral medications, carry out procedures, including
blood transfusions and cesarean sections, and provide newborn care/resuscitation [4]. However, health care systems
in many developing countries struggle to provide skilled
attendance and necessary emergency obstetric care [9,10].
Sixty million births per year world-wide currently occur
outside facilities, usually without skilled attendance [10].
When an obstetric emergency occurs, women delivering
in these settings are at high risk of poor outcomes due to
lack of appropriate services. Attempts to reduce perinatal
deaths generally focus on medical treatments, communityparticipatory approaches or health system interventions
[5,11-13]. Programs have used various combinations of
these interventions [14-22]; however, simultaneous integration of these strategies has not been adequately
evaluated to determine whether in aggregate they would
reduce perinatal deaths.
A brief discussion of justification for including specific
components in our intervention package follows. 1)
Community participatory approaches have suggested
reductions in maternal/neonatal mortality in Bolivia,
India, Bangladesh and Nepal [18-22]. Changing behavior of
families and communities during pregnancy and reducing
barriers to health service by addressing context-specific
delays (for example, birth preparedness, availability of
funds, transport mechanisms) have the potential to improve
outcomes in populations where most deliveries occur at
home or in primary health facilities [23]. 2) Traditional
birth attendants (TBAs) remain a major provider of delivery care, especially in settings where mortality rates
are highest [24]. Despite the lack of evidence supporting
TBA training as a single intervention to reduce mortality
[25], some research supports the inclusion of TBAs within
an improved health care system focusing on early recognition of obstetric complications and appropriate referral to
obstetric care facilities [13-15]. The Global Network’s
FIRST BREATH Trial, in which all birth attendants, including TBAs, were taught the World Health Organization’s
essential newborn care with emphasis on neonatal resuscitation, suggested a reduction of perinatal mortality associated with this training [26]. 3) Finally, facilities in settings
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with the worst outcomes are often unable to appropriately
implement emergency obstetric and neonatal care packages. Efforts to improve quality of care have focused on
in-service training, obstetric simulations/drills or perinatal
death audits to improve quality and institute solutions for
problems that caused fatalities [27].
This trial tested the hypothesis that teams of health care
providers, administrators and local residents can address
the limited access to quality obstetric and neonatal care
leading to a reduction in perinatal mortality in intervention
compared to control locations. These teams worked
with their communities and the existing health system
to implement a broad package of interventions including
community mobilization to establish and sustain mechanisms of transport and payment; training to recognize
obstetric emergencies and stabilization and appropriate
referral for women delivering at home or in first level
care facilities; and improvement of quality of care in
existing health facilities.

Methods
Study design and setting

This trial was undertaken by the Global Network for
Women’s and Children’s Health Research (GN) supported
by the Eunice Kennedy Shriver National Institute of Child
Health and Human Development [28]. The GN, a multicountry research network with seven research sites in
six countries, conducts research to evaluate interventions to reduce maternal and perinatal mortality and
morbidity. All seven GN sites participated in the trial,
including two in India (Belgaum and Nagpur), and sites
in Pakistan, Kenya, Zambia, Guatemala and Argentina.
Descriptions of the site populations and resources have
been published [28,29].
Details of the trial methods have been described [30].
Briefly, we conducted a community-based, two-arm cluster-randomized trial, including all pregnancies of residents
in 106 clusters. A cluster is a distinct geographic area with
approximately 500 births per year. Intervention start dates
ranged from March to August 2009 and the project intervention period was terminated for all sites on 30 September
2011. Data for the first six months of the implementation
were not included in the analysis data set. Thus, the
primary outcome period was 18 months (two sites) to
24 months (five sites). We also present outcome data
for the last six months of the intervention period and,
because a pregnancy registry is ongoing, the full year
following cessation of the intervention.
Subjects

Each site had a pre-existing, independent maternalnewborn health registry system to screen, enroll, and
track all pregnant women in the study clusters [28]. Registry administrators enrolled women during pregnancy,
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Figure 1 EmONC Study Organization.

obtained informed consent for the trial, and recorded
all intervention and control cluster delivery outcomes,
including stillbirths and neonatal deaths, and all deaths
of pregnant women through 42 days post-delivery or
pregnancy termination. Outcomes for all women with
births ≥1000 grams and or ≥28 weeks residing within
the study cluster for at least four weeks prior to delivery and who consented were included in study. Study
site ethics/institutional review boards, partnering US
institutions, and RTI International approved the protocol. The trial was registered at ClinicalTrials.gov (NCT
ID# NCT01073488).
Based on previously collected data, the 106 study clusters
had a mean perinatal death <7 days of age of 40 to 50 per
1,000 deliveries and an intra-class correlation coefficient
between 0.005 and 0.01 [26]. Using a two-sided hypothesis
test at 5% significance, these 106 clusters, with a minimum
of 18 month outcome data, provided a power of at least
80% to detect a 25% reduction in perinatal mortality.

Randomization and masking

Randomization was performed at the cluster level, stratifying by rates of the primary outcome (stillbirth and
early neonatal death) and number of deliveries. The
data coordinating center (Research Triangle Institute)
produced a computer-generated randomization algorithm
which assigned clusters at a 1:1 ratio within each stratum.
Because of the nature of the intervention, there was no
masking.
Intervention

Under direction of the GN Steering Committee, a team of
GN investigators, trainers with expertise in community
mobilization, TBA training and facility quality improvement
designed the intervention and provided study oversight
(See Figure 1). At each international site, an intervention
team of senior health, health system and study personnel,
meeting at least monthly, oversaw the project implementation. Trainers with extensive experience in community

Table 1 Training
Intervention

Purpose

Major areas of maternal/newborn
mortality addressed

Prior research

Community mobilization [18]

To ensure community recognition
of pregnancy complications and
their importance and to mobilize
resources for maternal and newborn
care including transportation to an
appropriate facility

The community training focused on
the major complications that killed
women and newborns such as
bleeding, preeclampsia/eclampsia,
infections, asphyxia and prematurity
and the importance of receiving
appropriate care for these conditions.

Studies conducted in Nepal,
Bangladesh, Pakistan etc.
suggested program effectively
facilitates community
change [19-23]

ACNM home-based
life-savings skills [31]

To train community birth attendants

Recognition of danger signs, stabilization
and referral of mother for obstetric
hemorrhage, preeclampsia/eclampsia,
sepsis; newborn resuscitation and
appropriate referral were emphasized

Studies conducted in Bangladesh,
Indonesia and Liberia suggest
that the curriculum effectively
provides essential skills to nurse
midwives and community birth
attendants [32-36]

Jhpeigo emergency obstetric
and newborn care curriculum [37]

To train facility-based health care
providers to manage obstetric
and neonatal complications and
to audit maternal, fetal and
neonatal deaths.

The modules addressed the major causes
of maternal, fetal and newborn mortality
(obstetric hemorrhage, preeclampsia/
eclampsia, infection, asphyxia, and
prematurity). Death audits, emergency
drills, and facility audits were part of
the training

EmONC training has been
evaluated [15] and the Jhpeigo
curriculum tested [38]; evidence
for audits to improve care
demonstrated [39]
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mobilization, others with experience in training community birth attendants and physicians with expertise in facility staff training were part of the country intervention
team and participated in training in the individual clusters.
In each study cluster, a cluster team comprising health
care providers, local residents and study personnel was
formed to develop and implement comprehensive interventions to improve the quality of obstetric and neonatal
care. These cluster teams worked within their community
and the local health care system to introduce these interventions. Maternal and perinatal mortality audits, facilitylevel provider training and facility reviews were conducted
as quality improvement activities at the facility level. In
addition, at the community level, village-level core groups
were formed which facilitated community meetings of
mothers, family and community birth attendants over
the course of the trial. In summary, the cluster teams
facilitated a multi-faceted intervention which included
the following:

 Community mobilization to establish village-level

core groups and to strengthen community capacity
to identify and address barriers to obstetric and
neonatal care such as recognition of complications
and transportation to a facility to manage the
complication [18]. Each village-level core group was
trained to move through a cycle to organize, plan,
explore, act, and to evaluate maternal and perinatal
outcomes within their community.
 Home-based Life Savings Skills (HBLSS) training
was provided for birth attendants and families to
recognize prolonged labor, infection, preeclampsia
and hemorrhage, and the use of appropriate
stabilization methods that can be employed in
homes and in first level care facilities [31-36]; and,
improvement of quality of care in existing health
facilities through a combination of facility staff
Emergency Obstetric and Newborn Care (EMONC)
training for clinical care of the major causes of

Randomized
Clusters: N=106

EmONC Intervention
Clusters: N=53

Control
Clusters: N=53

Enrollment
Women Screened: N=70,351
Eligible for Registry: N=68,499
Consented: N=68,351
Cluster Residents: N=59,189

Enrollment
Women Screened: N=66,830
Eligible for Registry: N=66,393
Consented: N=66,317
Cluster Residents: N=57,929

Exclusions (N=3,139)
Missing at delivery: N=535
Ineligible: N=2,604

Delivery
Pregnant women delivered: N=56,091
Infants ≥ 1000g: N=56,591
Stillbirths ≥ 1000g: N=1,422
Live births ≥ 1000g: N=55,169

Exclusions
Missing: N=747

Six Week Follow-up
Women with follow-up visit: N=55,712
Died prior to follow -up: N=76
Alive at follow-up: N=55,636
Infants with follow-up visit: N=56,223
Died prior to follow-up: N=3,127
Alive at follow-up: N=53,096

Figure 2 Consort diagram.

Exclusions (N=2,862)
Missing at delivery: N=419
Ineligible: N=2,433

Delivery
Pregnant women delivered: N=55,104
Infants ≥1000g: N=55,586
Stillbirths ≥ 1000g: N=1,485
Live births ≥ 1000g: N=54,101

Exclusions
Missing: N=562

Six Week Follow-up
Women with follow-up visit: N=54,822
Died prior to follow -up: N=77
Alive at follow-up: N=54,745
Infants with follow-up visit: N=55,306
Died prior to follow-up: N=3,037
Alive at follow-up: N=52,269
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maternal and newborn mortality [37], perinatal and
maternal death audits [38,39] and health facility
audits [29].
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and village-level core groups reaching the ‘act’ phase of
the community action cycle.
Study outcomes

The EmONC trial used a train-the-trainer model for the
three main components (HBLSS, community mobilization
and facility EMONC training) and the modules which
were focused on the major causes of maternal, fetal and
neonatal mortality (Table 1). Experienced trainers for each
of the three components were identified and these ‘master
trainers’ with input from other experts, selected and
modified the existing curriculum and led the train-thetrainer training as described below:
For HBLSS and community mobilization, the training
was combined and consisted of two in-country train-thetrainer sessions (an initial two-week period with approximately 70 hours of course work and practicum utilizing
the home-based life-saving skills curriculum. The community mobilization/HBLSS training emphasized the
Community Action Cycle and the relevant HBLSS modules
to identify and perform life-saving measures for the
conditions associated with maternal and early newborn
mortality (for example, post-partum hemorrhage, preeclampsia/eclampsia, low birth weight newborn care).
A second one-week in-country training of trainers and
cluster coordinators was held after 12 months. The incountry trainers then trained all of the community birth
attendants in the curriculum; these training sessions
included an initial three-day training followed by ongoing
(minimal of monthly) training and community meetings.
Additionally, the in-country EMONC trainer, usually
an experienced obstetric physician, received a three-day
course using a train-the-trainer model at a central location utilizing a modified version of the Jhpeigo EMONC
curriculum (37). This three-day training emphasized
the curriculum addressing post-partum hemorrhage,
preeclampsia/eclampsia and emergency preparedness.
The in-country trainers then carried out training for
the hospitals serving their intervention clusters with the
amount of training, including an initial three to five day
session to cover the essential elements with additional
time dedicated to follow-up training, varying based on
local assessment of facility needs. For each of these
components, the master trainers participated in central
training, followed by in-country training every six
months during the 24-month trial period. Each of the
training sessions included pre and post-tests to assess
knowledge and skills acquisition.
In anticipation that the package of interventions would
be better introduced in some clusters than others, we a
priori created a system for measuring the integrity of the
intervention, with credit given for reaching the targets for
four intervention measures including monthly cluster team
meetings, death audits, village-level core group activities

The primary outcome was perinatal mortality, defined as
the composite of stillbirth and seven-day neonatal mortality
per 1,000 births among births occurring at ≥28 weeks
gestation or birth weight ≥1000 g. Secondary outcomes
included rates of stillbirth (both fresh and macerated),
Table 2 Maternal and neonatal characteristics
Group
Treatment

Control

53

53

Argentina (6 clusters)

2,483

2,717

Guatemala (10 clusters)

6,898

5,405

Total clusters, N
Deliveries by country, N

Kenya (16 clusters)

5,962

7,401

Zambia (10 clusters)

6,455

7,423

Belgaum, India (20 clusters)

14,317

12,585

Nagpur, India (20 clusters)

6,535

5,966

Pakistan (24 clusters)
Mothers (N)

13,080

13,338

55,730

54,835

Maternal education, N (%)

55,325

54,524

No formal schooling

16,781 (30.3)

16,245 (29.8)

Primary

22,016 (39.8)

20,485 (37.6)

Secondary

13,476 (24.4)

14,879 (27.3)

University +

3,052 (5.5)

2,915 (5.3)

Maternal age, N (%)

55,602

54,757

< 20

6,870 (12.4)

6,838 (12.5)

20 to 35

46,320 (83.3)

45,339 (82.8)

> 35

2,412 (4.3)

2,580 (4.7)

Parity, N (%)

55,619

54,754

0

16,986 (30.5)

16,663 (30.4)

1 to 4

31,687 (57.0)

30,949 (56.5)

>4

6,946 (12.5)

7,142 (13.0)

56,223

55,306

Infants ≥1000 g, N
Birth weight, N (%)
1000 to 1499 g

56,223

55,306

687 (1.2)

739 (1.3)

1500 to 2499 g

6,170 (11.0)

5,431 (9.8)

≥2500 g

49,366 (87.8)

49,136 (88.8)

Gestational age, N (%)

56,128

55,197

51,681 (92.1)

51,409 (93.1)

4,447 (7.9)

3,788 (6.9)

56,174

55,233

Male

28,989 (51.6)

28,964 (52.4)

Female

27,185 (48.4)

26,269 (47.6)

Term
Preterm
Gender, N (%)
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seven-day neonatal mortality, 28-day neonatal mortality
and maternal death. Process measures, such as rates of
transport to hospital of mothers and newborns and
facility delivery, were also determined. Each of these
measures was assessed in both intervention and control
clusters through the registries, with registry teams distinct
from those implementing the interventions. We also collected extensive data on the intervention itself including
number and type of cluster and community meetings,
death audits and providers trained.

multinomial logistic regression model extensions for
ordinal outcomes. All analyses were performed using SAS
version 9.3 (SAS Institute, Cary, NC), with the exception
of the multinomial logistic regression models, which were
performed using SUDAAN 11.
Ethics approval and consent

The Ethics Review Committees of each participating institution and the data coordinating center (RTI International)
all approved the study protocol. Informed consent was
obtained from all women who participated in the study.

Statistical analyses

Data were entered at each study site with inter- and
intra-data edits and consistency checks performed. The
Data Monitoring Committee reviewed the data for safety
and efficacy. Generalized estimating equations (GEE)
extensions of a log-binomial for multivariate logistic
regression model that accounted for the study design
strata and correlation between outcomes in the same
cluster tested for differences in the primary outcome.
Secondary outcome analyses were conducted using GEE
extensions of either log-binomial or robust Poisson regression models for binary outcomes and clustered

Role of funding source

This trial was funded by grants from the US National
Institutes of Health (NIH). The NIH program officers
(LLW, MKT) participated in the protocol development
and study monitoring, and reviewed the manuscript.

Results
A total of 106 clusters, ranging from 6 in Argentina to 24
in Pakistan, were randomized, with 53 in each treatment
group (Figure 2). A total of 70,351 pregnant women were
screened in the intervention clusters and 66,830 in the

Table 3 The number of activities in intervention clusters by study site and where appropriate, means and percentages
Total

Argentina Guatemala

Kenya

Zambia

Belgaum, India Nagpur, India

Pakistan

Cluster team-led activities
Total activities, N

50,433

322

1,916

5,703

7,941

3,272

13,053

18,226

Facility training

1,309

94

115

183

27

497

80

313

HBLSS training

26,623

101

559

2,898

4054

698

7,569

10,744

Community training or meeting

21,060

111

1,095

2,595

3814

2,059

5,404

6,054

Other activity

1,441

16

147

99

46

18

0

1,115

1,459

76

364

140

302

295

209

73

Health facility provider training
Providers trained, N
Health facility reviews
Total facilities, N
Average reviews per facility,

304

3

23

22

9

69

130

48

4.1 (1.0)

5.0 (0.0)

4.8 (0.4)

3.5 (0.7)

5.0 (0.0)

4.6 (0.7)

3.5 (0.8)

4.3 (1.3)

382 (117.9)

180 (84.1)

309 (110.0)

1,287 (104.6)

321 (92.5)

2,474 (163.6)

Mean (SD)
Facility death audits,

5,039 (126.3) 86 (103.6)

N (% of total deaths)
Core groups
Core groups, N

3,721

7

50

231

160

667

1,028

1,578

119,200

187

1,681

9,960

8,861

33,802

11,949

52,760

Organize

3,396 (91.3)

3 (42.9)

50 (100.0)

216 (93.5)

159 (99.4)

665 (99.7)

932 (90.7)

1,371 (86.9)

Explore

3,536 (95.0)

5 (71.4)

49 (98.0)

231 (100.0)

159 (99.4)

666 (99.9)

886 (86.2)

1,540 (97.6)

Plan

3,486 (93.7)

6 (85.7)

44 (88.0)

231 (100.0) 160 (100.0)

661 (99.1)

828 (80.5)

1,556 (98.6)

Act

3,600 (96.7)

6 (85.7)

49 (98.0)

220 (95.2)

160 (100.0)

661 (99.1)

1,006 (97.9)

1,498 (94.9)

Evaluate

2,647 (71.1)

3 (42.9)

46 (92.0)

160 (69.3)

54 (33.8)

660 (99.0)

441 (42.9)

1,283 (81.3)

Total meetings, N
Community mobilization stage
reached by core groups, N (%)
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control clusters; of these, 59,189 (84%) and 57,929 (87%)
women were eligible and consented in the intervention
and control groups, respectively. Those women excluded,
for the most part, did not reside in the cluster for a full
four weeks prior to delivery. An additional 3,139 (4.5%)
and 2,862 (4.3%) deliveries in intervention and control
clusters were excluded at delivery due to missing data
or other ineligibility criteria. Outcomes were obtained
for >99% of eligible women at six-weeks post-delivery
(55,712 and 54,822 in the intervention and control clusters,
respectively).
Demographic characteristics of the intervention and
control participants are shown in Table 2. Overall, almost
one-third of women had no formal schooling and 5%
had university-level education. Approximately 12% of
the mothers were <20 years of age and 83% were 20 to
35 years old. In both groups, about 30% of the women
were primiparous; over 12% had more than four prior
pregnancies. Table 2 also shows the birthweight, gestational age, and gender distributions. Although there
were small differences, none were statistically significant
at P <0.05.
Table 3 shows the number of interventions applied in
the treatment clusters by site, emphasizing the great
amount of work done by the site and cluster teams. The
53 intervention cluster teams (one per cluster) led more
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than 50,000 cluster-level activities, including meetings,
trainings and other community sensitization activities. The
specific activities included facility training (n = 1,309),
HBLSS training (n = 26,623), community mobilization
training (n = 21,060) and other meetings (n = 1,441). There
were a total of 304 facility reviews; on average, each facility
was reviewed more than four times during the trial. There
were 5,039 facility death audits. In each site, more death audits were completed than there were study deaths because
facility audits included deaths of women and their newborns from non-study areas. Village-level core groups
went through the community action cycle stages (organize,
explore, plan, act and evaluate) generally in sequential
order; however, due to occasional division of one into two
core groups, a few appear to start the sequence at midcycle. The primary issues identified during these activities
were difficulty recognizing that the mother/baby had a
problem requiring treatment, lack of transportation and
lack of funds to pay for facility care (data not shown).
Altogether, 96.7% of the village-level core groups reached
the act stage by the end of the trial. Using these data and
the a priori criteria for implementing the intervention,
37.7% of the clusters met two or fewer criteria, 32.1% of the
clusters met three criteria, and 30.2% met all four criteria.
Table 4 summarizes the indicators of the antenatal and
delivery care by intervention and control groups after

Table 4 Indicators of quality of care by treatment group
Group
Clusters, N
Mothers with infants ≥1000 g, N

Intervention

Control

53

53

55,730

54,835

59.7 (55.8, 63.7)

59.7 (55.8, 63.5)

P-value

Indicators of quality care, Mean (95% CI)
Attended at least one antenatal care class

0.6687

Access to an emergency fund/plan for hospital delivery

61.3 (54.3, 68.3)

56.8 (50.2, 63.4)

0.3541

Birth attendant identified prior to birth

87.1 (82.6, 91.7)

84.6 (79.5, 89.7)

0.3269

Identified birth attendant present at birth

71.0 (66.8, 75.2)

71.8 (66.5, 77.2)

0.8045

Transport identified prior to birth

62.0 (55.5, 68.6)

62.3 (56.4, 68.1)

0.9570

Received tetanus toxoid vaccine

87.9 (86.3, 89.4)

87.9 (86.4, 89.5)

0.2808

Received prenatal vitamins/iron

89.6 (87.9, 91.4)

89.8 (88.1, 91.4)

0.1792

Received syphilis test

18.5 (14.9, 23.0)

19.5 (15.4, 24.8)

0.5237

Received HIV test

71.2 (69.2, 73.2)

71.3 (69.1, 73.4)

0.9457

Cesarean section (of all deliveries)

11.7 (10.1, 13.2)

11.9 (10.4, 13.4)

0.5022

Physician or nurse/midwife deliveries

65.0 (62.5, 67.6)

64.8 (61.9, 67.6)

0.7053

Traditional birth attendant deliveries

32.4 (26.3, 38.4)

32.5 (26.2, 38.9)

0.8998

Hospital deliveries

38.6 (32.4, 44.7)

40.3 (33.6, 47.0)

0.4801

Clinic/health center deliveries

24.6 (20.4, 28.8)

24.0 (19.3, 28.7)

0.9131

Clean razor was used to cut cord

87.6 (86.0, 89.3)

87.5 (85.9, 89.2)

0.4844

Birth attendant used new gloves

95.5 (94.3, 96.6)

95.7 (94.8, 96.6)

0.5934

2.6 (1.9, 3.3)

3.1 (2.1, 4.1)

0.3769

Newborn resuscitated with bag and mask
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the trial’s initiation. In both arms, almost 60% of women
attended at least one antenatal class. More than threefifths of women in both groups reported having access
to emergency transport, if necessary, for delivery, and
the rate of facility delivery in both groups was 65%. In
the intervention group, 61.3% of women reported access
to emergency funds in case a facility delivery was needed,
compared to 56.8% in the control group and 87.1% of
women in the intervention group had identified a birth
attendant prior to delivery compared to 84.6% in the
control group. However, neither of these differences
rose to statistical significance.
Table 5 first shows the primary outcome of perinatal
mortality and the secondary outcomes for the 18 to 24
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months of the intervention. In both the intervention and
the control clusters, the mean perinatal mortality was
40.1/1,000 births (P = 0.9996). None of the secondary
outcomes differed significantly between groups. Next, to
determine whether differences developed only late in the
project, we evaluated each outcome in the last six months
of the intervention. No significant differences in outcome
emerged. Finally, we examined the primary outcomes for
intervention compared to control clusters in the 12
months post-trial and found no significant differences in
any outcome measure. We also compared the outcomes
in the better performing intervention clusters to their
controls for the entire intervention time period, and for
the last six months of the intervention (Table 6). There

Table 5 Neonatal and maternal mortality outcomes by treatment for all clusters
Group
Intervention

Control

53

53

56,223

55,306

Perinatal mortality (<7 days) (Rate/1,000)

40.1 (37.3, 42.9)

40.1 (37.4, 42.8)

0.9996

Stillbirths (Rate/1,000)

21.8 (19.8, 23.9)

22.6 (20.5, 24.6)

0.6177

Clusters, N

P-value

Outcomes for full intervention period
Births ≥1000 g, N
Outcomes - Mean (95% CI)

Fresh stillbirth (Rate/1,000)

15.2 (13.4, 17.0)

15.5 (14.0, 17.0)

0.8082

Early neonatal mortality (<7 days) (Rate/1,000)

18.7 (17.3, 20.1)

18.2 (16.6, 19.7)

0.5950

Neonatal mortality (<28 days) (Rate/1,000)

23.8 (22.0, 25.5)

22.5 (20.6, 24.5)

0.3362

Fresh stillbirths + neonatal deaths <7 days (Rate/1,000)

33.8 (31.2, 36.3)

33.4 (31.2, 35.5)

0.8105

125.1 (97.7, 160.2)

130.9 (104.5, 163.9)

0.7321

15,412

15,180

Perinatal mortality (<7 days) (Rate/1,000)

39.6 (35.8, 43.4)

41.4 (37.4, 45.5)

0.5043

Stillbirths (Rate/1,000)

21.6 (18.8, 24.4)

22.9 (19.7, 26.2)

0.5491

Maternal mortality (<42 days) (Rate/100,000)
Outcomes for final six months of intervention period
Births ≥1,000 g, N
Outcomes - Mean (95% CI)

Fresh stillbirth (Rate/1,000)

15.2 (12.7, 17.7)

14.5 (12.2, 16.8)

0.6826

Early neonatal mortality (<7 days) (Rate/1,000)

18.7 (16.7, 20.8)

19.0 (16.8, 21.3)

0.8458

Neonatal mortality (<28 days) (Rate/1,000)

23.4 (21.0, 25.8)

22.9 (20.3, 25.6)

0.7822

Fresh stillbirths + neonatal deaths <7 days (Rate/1,000)

33.4 (30.1, 36.8)

33.4 (30.3, 36.4)

0.9734

109.1 (64.5, 184.5)

78.3 (44.0, 139.3)

0.2799

27,852

26,356

Perinatal mortality (<7 days) (Rate/1,000)

37.9 (34.0, 41.7)

36.6 (33.2, 40.0)

0.6202

Stillbirths (Rate/1,000)

21.7 (19.2, 24.2)

21.1 (18.9, 23.4)

0.7406

Maternal mortality (<42 days) (Rate/100,000)
Outcomes for 12-months post-intervention period
Births ≥1,000 g, N
Outcomes - Mean (95% CI)

Fresh stillbirth (Rate/1,000)

14.8 (12.7, 16.9)

14.1 (12.2, 16.0)

0.6271

Early neonatal mortality (<7 days) (Rate/1,000)

16.4 (14.5, 18.4)

15.9 (13.8, 18.0)

0.7136

Neonatal mortality (<28 days) (Rate/1,000)

21.4 (19.0, 23.8)

20.0 (17.5, 22.5)

0.4311

Fresh stillbirths + neonatal deaths <7 days (Rate/1,000)

31.3 (27.7, 34.9)

29.7 (26.6, 32.9)

0.5126
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Table 6 Neonatal and maternal outcomes for well performing intervention clusters and control clusters in the same
strata for the entire intervention and restricted to the last six months of the intervention
Group
Well performing
intervention clusters

Control
clusters same strata

33

36

40,897

42,662

40.6 (37.0, 44.1)

40.4 (37.0, 43.7)

0.9404

21.8 (19.2, 24.5)

23.3 (21.0, 25.6)

0.4087

Clusters, N

P-value

Outcomes for full intervention period
Births ≥1,000 g, N
Primary outcome - Mean (95% CI)
Perinatal mortality (<7 days) (Rate/1,000)
Secondary outcomes - Mean (95% CI)
Stillbirths (Rate/1,000)
Fresh stillbirth (Rate/1,000)

14.9 (12.5, 17.3)

15.7 (14.0, 17.4)

0.5504

Early neonatal mortality (<7 days) (Rate/1,000)

19.2 (17.6, 20.8)

17.8 (16.2, 19.3)

0.2095

Neonatal mortality (<28 days) (Rate/1,000)

24.6 (22.6, 26.7)

21.9 (20.0, 23.7)

0.0516

Fresh stillbirths + neonatal deaths <7 days (Rate/1,000)

33.9 (30.6, 37.1)

33.2 (30.4, 36.0)

0.7365

103.2 (71.7, 148.5)

108.5 (76.0, 154.8)

0.7425

10,514

10,568

38.1 (33.6, 42.6)

41.3 (36.5, 46.1)

0.3666

Stillbirths (Rate/1,000)

21.3 (18.0, 24.6)

23.2 (19.4, 27.0)

0.4976

Fresh stillbirth (Rate / 1,000)

14.4 (11.3, 17.5)

13.3 (10.9, 15.8)

0.6080

Early neonatal mortality (<7 days) (Rate/1,000)

17.7 (14.8, 20.6)

18.7 (15.7, 21.7)

0.6118

Neonatal mortality (<28 days) (Rate/1,000)

23.0 (19.3, 26.8)

22.8 (19.1, 26.5)

0.9220

Fresh stillbirths + neonatal deaths <7 days (Rate/1,000)

31.4 (27.3, 35.6)

32.1 (28.7, 35.5)

0.8153

Maternal mortality (<42 days) (Rate/100,000)
Outcomes for final six months of intervention period
Births ≥1,000 g, N
Primary outcome - Mean (95% CI)
Perinatal mortality (<7 days) (Rate/1,000)
Secondary outcomes - Mean (95% CI)

were no significant differences in outcomes in either
time period.

Discussion
In geographic areas with high maternal and perinatal
mortality in seven sites in six countries, we found that a
multipronged intervention that included: 1) community
mobilization and birth attendant education focusing on
birth planning and transportation to a hospital; 2) birth
attendant recognition of complications, stabilization and
appropriate, timely referral to a hospital; and 3) hospital
staff training focusing on appropriate and timely management of medical complications did not reduce perinatal
mortality.
We have considered the potential reasons why our
efforts did not achieve the hypothesized outcomes.
One possibility is that we had the right group of interventions to achieve an important improvement in outcomes,
but that the intervention was not carried out sufficiently
well in enough clusters to impact either the process
measures or the outcomes. However, based on our ongoing
monitoring systems, we documented that the intervention

components were generally implemented with high fidelity.
The very large number of activities documented plus the
fact that there was no improvement in outcomes even
among the best performing clusters, suggests this was not
the case. Another possibility is that our chosen package of
interventions was not implementable with the resources
or time allowed for this project. However, substantial
resources were allocated to the intervention (each study
site had a budget over the two years of approximately
$500,000 USD or on average about $60,000 USD per
intervention cluster) and many of the clusters achieved
substantial compliance in most components of the intervention. That there were no observable improvements in
outcome in the final six months of the intervention or
even in the year after the intervention ceased, suggests
that insufficient time was not responsible for the lack of
observed improvement in outcome. Another possibility is
that although we had three intervention components,
most sites appeared to give more attention to community
mobilization and community birth attendant training and
less to hospital staff training. Since a well-functioning
hospital and a trained, motivated staff seem crucial for
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achieving the level of mortality reduction hoped for in this
study, it may be that hospital training was insufficient.
However, a substantial amount of hospital training occurred, and potential areas for improvement were made
apparent to the hospital administrators and staff by the
facility and mortality audits.
A more likely explanation for the lack of improvement
in outcomes in the intervention clusters is that the
deficiencies in the health systems were beyond potential
improvement by our package of interventions. Without
appropriate complementary efforts by the ministries of
health or other agencies to strengthen the health care
infrastructure at referral facilities to ensure availability of
skilled personnel and access to comprehensive emergency
obstetric care including appropriate essential medications,
supplies, and equipment, it is likely that interventions
predominantly focusing on community mobilization and
birth attendant training alone are insufficient to achieve
the hoped-for results [22-25,29]. Community mobilization
or birth attendant training might only help to reduce
mortality beyond a certain level if there is a concurrent
improvement in the capacity for managing obstetric
and neonatal emergencies. Our study suggests that the
weaknesses of the delivering facilities and health systems
in the participating sites, including the lack of essential
medications, supplies and equipment, were not adequately
addressed by the three-pronged strategy used in this
trial [29].
This study had a number of strengths including the
participation of seven sites in six countries and the large
number of clusters. The populations in the intervention
and the control arms were similar. A further strength is
that the study was performed in locations which had
ongoing pregnancy registries with excellent follow-up of
mothers and infants, and with registry personnel distinct
from trial staff, reducing potential for bias. That data
collection continued for a full year after the intervention
ceased is a further strength. A potential weakness was that
all the clusters did not achieve complete implementation,
although a substantial amount of work was done in every
cluster. Another potential weakness was that because the
intervention could not be blinded, some of the control
clusters may have adopted a portion of the trial interventions. We do not think that contamination occurred
frequently, but cannot rule out this possibility.

Conclusions
Our results are of major public health importance. First,
rolling out programs similar to the one tested here
without formal testing of their effectiveness will not
help to improve pregnancy-related outcomes nor achieve
progress toward Millennium Development Goals 4 and 5
to reduce maternal and child mortality. Second, we believe
that substantial attention to creating a system of maternal
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and neonatal care with adequate supplies and infrastructure, in addition to training of existing personnel, is
needed to achieve substantial improvements in pregnancy
outcomes - specifically systems that include appropriate
access to delivery facilities for all women, facilities with
sufficient equipment and access to essential medications,
and especially a well-trained and motivated staff with a
high degree of skill in treating obstetric and neonatal
emergencies. Our results suggest that in many lowresource settings, it may take substantial resources and
time to create a sustainable and functioning maternal
and newborn care system to accomplish this goal than
were available for the current project.
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